Vertex Pharmaceuticals Incorporated Share Price Sao Paulo
Stocks
VRTX34
BRVRTXBDR001
Pharmaceuticals
|
Market Closed -
Sao Paulo
07:46:17 19/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 79.36 BRL | -0.30% |
|
+3.77% | +1.43% |
| 15/10 | Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $654 From $653 | MT |
| 09/10 | Vertex Pharmaceuticals Says Alyftrek Delivers Pancreatic Function Recovery in Some Children | MT |
| Market Cap | 13TCr 65TCr 12TCr 11TCr 9.75TCr 18TCr 12,35700Cr 19TCr 1,29100Cr 51TCr 6,46700Cr 49TCr 48TCr 20,63000Cr | P/E 2026 * |
34.3x | P/E 2027 * | 27.6x |
|---|---|---|---|---|---|
| Enterprise Value | 12TCr 63TCr 11TCr 10TCr 9.32TCr 18TCr 11,81400Cr 18TCr 1,23400Cr 48TCr 6,18300Cr 47TCr 46TCr 19,72300Cr | EV / Sales 2026 * |
9.4x | EV / Sales 2027 * | 8.44x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -0.30% | ||
| 1 week | +3.77% | ||
| Current month | -7.57% | ||
| 1 month | -7.05% | ||
| 3 months | +2.90% | ||
| 6 months | +16.04% | ||
| Current year | +1.43% |
| 1 week | 79 |  | 79.6 |
| 1 month | 76.36 | | 86.22 |
| Current year | 65.18 | | 89.01 |
| 1 year | 65.18 | | 89.01 |
| 3 years | 52.29 | | 93.56 |
| 5 years | 31.33 | | 93.56 |
| 10 years | 20.29 | | 93.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 01/04/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 10/04/2019 |
Sean Daughtry
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 01/01/1998 |
Jeffrey Leiden
CHM | Chairman | 70 | 01/05/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 18/06/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.30% | +3.77% | - | - | 13TCr | |
| +3.49% | +10.04% | +58.68% | +119.56% | 1,10600Cr | |
| +2.19% | +4.32% | +33.88% | +69.52% | 61TCr | |
| +2.26% | +5.37% | +24.57% | +97.69% | 50TCr | |
| +2.58% | +8.37% | +38.71% | +63.14% | 37TCr | |
| +3.25% | +4.45% | +71.80% | +44.44% | 35TCr | |
| +1.85% | +6.04% | +21.47% | +49.17% | 29TCr | |
| +1.76% | +6.07% | +0.43% | +20.98% | 26TCr | |
| +3.29% | +6.32% | +44.71% | +57.43% | 23TCr | |
| +2.25% | +5.81% | +27.13% | +101.17% | 19TCr | |
| Average | +1.81% | +4.19% | +35.71% | +69.23% | 43.33TCr | |
| Weighted average by Cap. | +1.38% | +4.67% | +40.82% | +80.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.33TCr 6.66TCr 1.18TCr 1.09TCr 991.89Cr 1.86TCr 1,25700Cr 1.9TCr 13TCr 5.16TCr 66TCr 4.98TCr 4.87TCr 2,09900Cr | 1.46TCr 7.31TCr 1.3TCr 1.2TCr 1.09TCr 2.05TCr 1,38000Cr 2.08TCr 14TCr 5.66TCr 72TCr 5.46TCr 5.35TCr 2,30300Cr |
| Net income | 389.06Cr 1.95TCr 346.3Cr 320.95Cr 290.84Cr 546.59Cr 37TCr 555.74Cr 3.85TCr 1.51TCr 19TCr 1.46TCr 1.43TCr 62TCr | 489.21Cr 2.45TCr 435.45Cr 403.57Cr 365.7Cr 687.29Cr 46TCr 698.79Cr 4.84TCr 1.9TCr 24TCr 1.84TCr 1.8TCr 77TCr |
| Net Debt | -573.26Cr -2.88TCr -510.26Cr -472.9Cr -428.53Cr -805.36Cr -54TCr -818.84Cr -5.67TCr -2.23TCr -28TCr -2.15TCr -2.11TCr -91TCr | -754.36Cr -3.78TCr -671.45Cr -622.3Cr -563.9Cr -1.06TCr -71TCr -1.08TCr -7.47TCr -2.93TCr -37TCr -2.83TCr -2.77TCr -1,19300Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | R$79.36 | -0.30% | 1,888 |
| 16/26/16 | R$79.60 | +0.71% | 1 |
| 14/26/14 | R$79.04 | +3.35% | 2 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
- VRTX34 Stock
Select your edition
All financial news and data tailored to specific country editions
